nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.034	0.248	CbGbCtD
Disopyramide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0258	0.188	CbGbCtD
Disopyramide—CYP3A4—Betamethasone—ankylosing spondylitis	0.0221	0.161	CbGbCtD
Disopyramide—CYP3A4—Prednisolone—ankylosing spondylitis	0.0218	0.159	CbGbCtD
Disopyramide—CYP3A4—Prednisone—ankylosing spondylitis	0.0206	0.15	CbGbCtD
Disopyramide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0129	0.0938	CbGbCtD
Disopyramide—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.0049	0.00569	CcSEcCtD
Disopyramide—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.0049	0.00569	CcSEcCtD
Disopyramide—Weight increased—Prednisolone—ankylosing spondylitis	0.00486	0.00564	CcSEcCtD
Disopyramide—Sweating increased—Triamcinolone—ankylosing spondylitis	0.00479	0.00555	CcSEcCtD
Disopyramide—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.00478	0.00554	CcSEcCtD
Disopyramide—Coma—Methotrexate—ankylosing spondylitis	0.00473	0.00548	CcSEcCtD
Disopyramide—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.00469	0.00544	CcSEcCtD
Disopyramide—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.00469	0.00544	CcSEcCtD
Disopyramide—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.00463	0.00536	CcSEcCtD
Disopyramide—Cardiac failure—Prednisone—ankylosing spondylitis	0.0046	0.00534	CcSEcCtD
Disopyramide—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.00455	0.00527	CcSEcCtD
Disopyramide—Muscular weakness—Betamethasone—ankylosing spondylitis	0.00455	0.00527	CcSEcCtD
Disopyramide—Weight increased—Triamcinolone—ankylosing spondylitis	0.00447	0.00518	CcSEcCtD
Disopyramide—Weight increased—Methylprednisolone—ankylosing spondylitis	0.00446	0.00517	CcSEcCtD
Disopyramide—Psychotic disorder—Prednisone—ankylosing spondylitis	0.00439	0.00509	CcSEcCtD
Disopyramide—Bradycardia—Prednisolone—ankylosing spondylitis	0.00435	0.00505	CcSEcCtD
Disopyramide—Sweating increased—Betamethasone—ankylosing spondylitis	0.00434	0.00503	CcSEcCtD
Disopyramide—Sweating increased—Dexamethasone—ankylosing spondylitis	0.00434	0.00503	CcSEcCtD
Disopyramide—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00427	0.00495	CcSEcCtD
Disopyramide—Hypokalaemia—Prednisone—ankylosing spondylitis	0.00409	0.00474	CcSEcCtD
Disopyramide—Weight increased—Dexamethasone—ankylosing spondylitis	0.00406	0.0047	CcSEcCtD
Disopyramide—Weight increased—Betamethasone—ankylosing spondylitis	0.00406	0.0047	CcSEcCtD
Disopyramide—Bradycardia—Triamcinolone—ankylosing spondylitis	0.004	0.00464	CcSEcCtD
Disopyramide—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00399	0.00463	CcSEcCtD
Disopyramide—Muscular weakness—Prednisone—ankylosing spondylitis	0.00396	0.00459	CcSEcCtD
Disopyramide—Abdominal distension—Prednisone—ankylosing spondylitis	0.00391	0.00453	CcSEcCtD
Disopyramide—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00382	0.00443	CcSEcCtD
Disopyramide—Sweating increased—Prednisone—ankylosing spondylitis	0.00378	0.00438	CcSEcCtD
Disopyramide—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00363	0.00421	CcSEcCtD
Disopyramide—Bradycardia—Betamethasone—ankylosing spondylitis	0.00363	0.00421	CcSEcCtD
Disopyramide—Neutropenia—Prednisone—ankylosing spondylitis	0.00363	0.00421	CcSEcCtD
Disopyramide—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00358	0.00414	CcSEcCtD
Disopyramide—Weight increased—Prednisone—ankylosing spondylitis	0.00353	0.0041	CcSEcCtD
Disopyramide—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00351	0.00407	CcSEcCtD
Disopyramide—Vision blurred—Prednisolone—ankylosing spondylitis	0.00351	0.00407	CcSEcCtD
Disopyramide—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00351	0.00406	CcSEcCtD
Disopyramide—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00345	0.004	CcSEcCtD
Disopyramide—Depression—Prednisone—ankylosing spondylitis	0.00345	0.004	CcSEcCtD
Disopyramide—Angioedema—Prednisolone—ankylosing spondylitis	0.0034	0.00394	CcSEcCtD
Disopyramide—Malaise—Prednisolone—ankylosing spondylitis	0.00336	0.00389	CcSEcCtD
Disopyramide—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00335	0.00389	CcSEcCtD
Disopyramide—Vertigo—Prednisolone—ankylosing spondylitis	0.00334	0.00388	CcSEcCtD
Disopyramide—Syncope—Prednisolone—ankylosing spondylitis	0.00334	0.00387	CcSEcCtD
Disopyramide—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00327	0.00379	CcSEcCtD
Disopyramide—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00319	0.0037	CcSEcCtD
Disopyramide—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00319	0.0037	CcSEcCtD
Disopyramide—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00318	0.00368	CcSEcCtD
Disopyramide—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00317	0.00367	CcSEcCtD
Disopyramide—Bradycardia—Prednisone—ankylosing spondylitis	0.00316	0.00367	CcSEcCtD
Disopyramide—Discomfort—Prednisolone—ankylosing spondylitis	0.00313	0.00363	CcSEcCtD
Disopyramide—Angioedema—Triamcinolone—ankylosing spondylitis	0.00313	0.00363	CcSEcCtD
Disopyramide—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00312	0.00362	CcSEcCtD
Disopyramide—Malaise—Triamcinolone—ankylosing spondylitis	0.00309	0.00358	CcSEcCtD
Disopyramide—Malaise—Methylprednisolone—ankylosing spondylitis	0.00308	0.00357	CcSEcCtD
Disopyramide—Vertigo—Triamcinolone—ankylosing spondylitis	0.00308	0.00357	CcSEcCtD
Disopyramide—Syncope—Triamcinolone—ankylosing spondylitis	0.00307	0.00356	CcSEcCtD
Disopyramide—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00307	0.00356	CcSEcCtD
Disopyramide—Syncope—Methylprednisolone—ankylosing spondylitis	0.00306	0.00355	CcSEcCtD
Disopyramide—Oedema—Prednisolone—ankylosing spondylitis	0.00304	0.00352	CcSEcCtD
Disopyramide—Dysuria—Methotrexate—ankylosing spondylitis	0.00303	0.00352	CcSEcCtD
Disopyramide—Neutropenia—Methotrexate—ankylosing spondylitis	0.00303	0.00352	CcSEcCtD
Disopyramide—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00301	0.00349	CcSEcCtD
Disopyramide—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.003	0.00348	CcSEcCtD
Disopyramide—Shock—Prednisolone—ankylosing spondylitis	0.00299	0.00347	CcSEcCtD
Disopyramide—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00299	0.00346	CcSEcCtD
Disopyramide—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00294	0.0034	CcSEcCtD
Disopyramide—Drowsiness—Methotrexate—ankylosing spondylitis	0.00289	0.00335	CcSEcCtD
Disopyramide—Depression—Methotrexate—ankylosing spondylitis	0.00288	0.00334	CcSEcCtD
Disopyramide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00288	0.00334	CcSEcCtD
Disopyramide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00288	0.00334	CcSEcCtD
Disopyramide—Discomfort—Triamcinolone—ankylosing spondylitis	0.00288	0.00334	CcSEcCtD
Disopyramide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00287	0.00333	CcSEcCtD
Disopyramide—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00285	0.0033	CcSEcCtD
Disopyramide—Angioedema—Betamethasone—ankylosing spondylitis	0.00284	0.00329	CcSEcCtD
Disopyramide—Angioedema—Dexamethasone—ankylosing spondylitis	0.00284	0.00329	CcSEcCtD
Disopyramide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00281	0.00326	CcSEcCtD
Disopyramide—Malaise—Dexamethasone—ankylosing spondylitis	0.0028	0.00325	CcSEcCtD
Disopyramide—Malaise—Betamethasone—ankylosing spondylitis	0.0028	0.00325	CcSEcCtD
Disopyramide—Oedema—Triamcinolone—ankylosing spondylitis	0.00279	0.00324	CcSEcCtD
Disopyramide—Vertigo—Betamethasone—ankylosing spondylitis	0.00279	0.00324	CcSEcCtD
Disopyramide—Vertigo—Dexamethasone—ankylosing spondylitis	0.00279	0.00324	CcSEcCtD
Disopyramide—Syncope—Betamethasone—ankylosing spondylitis	0.00279	0.00323	CcSEcCtD
Disopyramide—Syncope—Dexamethasone—ankylosing spondylitis	0.00279	0.00323	CcSEcCtD
Disopyramide—Arrhythmia—Prednisone—ankylosing spondylitis	0.00278	0.00322	CcSEcCtD
Disopyramide—Shock—Triamcinolone—ankylosing spondylitis	0.00275	0.00319	CcSEcCtD
Disopyramide—Insomnia—Prednisolone—ankylosing spondylitis	0.00275	0.00319	CcSEcCtD
Disopyramide—Shock—Methylprednisolone—ankylosing spondylitis	0.00274	0.00318	CcSEcCtD
Disopyramide—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00273	0.00316	CcSEcCtD
Disopyramide—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00273	0.00316	CcSEcCtD
Disopyramide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00273	0.00316	CcSEcCtD
Disopyramide—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00271	0.00314	CcSEcCtD
Disopyramide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.0027	0.00313	CcSEcCtD
Disopyramide—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.0027	0.00313	CcSEcCtD
Disopyramide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.0027	0.00312	CcSEcCtD
Disopyramide—Discomfort—Betamethasone—ankylosing spondylitis	0.00261	0.00303	CcSEcCtD
Disopyramide—Discomfort—Dexamethasone—ankylosing spondylitis	0.00261	0.00303	CcSEcCtD
Disopyramide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00261	0.00302	CcSEcCtD
Disopyramide—Pain—Prednisolone—ankylosing spondylitis	0.0026	0.00301	CcSEcCtD
Disopyramide—Hepatitis—Methotrexate—ankylosing spondylitis	0.0026	0.00301	CcSEcCtD
Disopyramide—Vision blurred—Prednisone—ankylosing spondylitis	0.00255	0.00296	CcSEcCtD
Disopyramide—Oedema—Dexamethasone—ankylosing spondylitis	0.00254	0.00294	CcSEcCtD
Disopyramide—Oedema—Betamethasone—ankylosing spondylitis	0.00254	0.00294	CcSEcCtD
Disopyramide—Insomnia—Triamcinolone—ankylosing spondylitis	0.00253	0.00293	CcSEcCtD
Disopyramide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00252	0.00292	CcSEcCtD
Disopyramide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00251	0.00291	CcSEcCtD
Disopyramide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00251	0.00291	CcSEcCtD
Disopyramide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.0025	0.0029	CcSEcCtD
Disopyramide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.0025	0.0029	CcSEcCtD
Disopyramide—Shock—Dexamethasone—ankylosing spondylitis	0.00249	0.00289	CcSEcCtD
Disopyramide—Shock—Betamethasone—ankylosing spondylitis	0.00249	0.00289	CcSEcCtD
Disopyramide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00249	0.00289	CcSEcCtD
Disopyramide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00248	0.00288	CcSEcCtD
Disopyramide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00248	0.00288	CcSEcCtD
Disopyramide—Angioedema—Prednisone—ankylosing spondylitis	0.00247	0.00287	CcSEcCtD
Disopyramide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00246	0.00285	CcSEcCtD
Disopyramide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00245	0.00284	CcSEcCtD
Disopyramide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00245	0.00284	CcSEcCtD
Disopyramide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00245	0.00284	CcSEcCtD
Disopyramide—Malaise—Prednisone—ankylosing spondylitis	0.00244	0.00283	CcSEcCtD
Disopyramide—Vertigo—Prednisone—ankylosing spondylitis	0.00243	0.00282	CcSEcCtD
Disopyramide—Syncope—Prednisone—ankylosing spondylitis	0.00243	0.00281	CcSEcCtD
Disopyramide—Anorexia—Dexamethasone—ankylosing spondylitis	0.00242	0.0028	CcSEcCtD
Disopyramide—Anorexia—Betamethasone—ankylosing spondylitis	0.00242	0.0028	CcSEcCtD
Disopyramide—Urticaria—Prednisolone—ankylosing spondylitis	0.00241	0.0028	CcSEcCtD
Disopyramide—Fatigue—Triamcinolone—ankylosing spondylitis	0.00241	0.00279	CcSEcCtD
Disopyramide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.0024	0.00279	CcSEcCtD
Disopyramide—Pain—Triamcinolone—ankylosing spondylitis	0.00239	0.00277	CcSEcCtD
Disopyramide—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00238	0.00276	CcSEcCtD
Disopyramide—Hypotension—Betamethasone—ankylosing spondylitis	0.00237	0.00275	CcSEcCtD
Disopyramide—Hypotension—Dexamethasone—ankylosing spondylitis	0.00237	0.00275	CcSEcCtD
Disopyramide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.0023	0.00267	CcSEcCtD
Disopyramide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.0023	0.00266	CcSEcCtD
Disopyramide—Insomnia—Betamethasone—ankylosing spondylitis	0.00229	0.00266	CcSEcCtD
Disopyramide—Insomnia—Dexamethasone—ankylosing spondylitis	0.00229	0.00266	CcSEcCtD
Disopyramide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00228	0.00264	CcSEcCtD
Disopyramide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00228	0.00264	CcSEcCtD
Disopyramide—Discomfort—Prednisone—ankylosing spondylitis	0.00228	0.00264	CcSEcCtD
Disopyramide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00223	0.00259	CcSEcCtD
Disopyramide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00223	0.00259	CcSEcCtD
Disopyramide—Urticaria—Triamcinolone—ankylosing spondylitis	0.00222	0.00257	CcSEcCtD
Disopyramide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00221	0.00257	CcSEcCtD
Disopyramide—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00221	0.00257	CcSEcCtD
Disopyramide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00221	0.00256	CcSEcCtD
Disopyramide—Oedema—Prednisone—ankylosing spondylitis	0.00221	0.00256	CcSEcCtD
Disopyramide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.0022	0.00255	CcSEcCtD
Disopyramide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.0022	0.00255	CcSEcCtD
Disopyramide—Fatigue—Dexamethasone—ankylosing spondylitis	0.00219	0.00253	CcSEcCtD
Disopyramide—Fatigue—Betamethasone—ankylosing spondylitis	0.00219	0.00253	CcSEcCtD
Disopyramide—Shock—Prednisone—ankylosing spondylitis	0.00217	0.00252	CcSEcCtD
Disopyramide—Pain—Betamethasone—ankylosing spondylitis	0.00217	0.00251	CcSEcCtD
Disopyramide—Pain—Dexamethasone—ankylosing spondylitis	0.00217	0.00251	CcSEcCtD
Disopyramide—Skin disorder—Prednisone—ankylosing spondylitis	0.00214	0.00249	CcSEcCtD
Disopyramide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00213	0.00247	CcSEcCtD
Disopyramide—Vision blurred—Methotrexate—ankylosing spondylitis	0.00213	0.00247	CcSEcCtD
Disopyramide—Anorexia—Prednisone—ankylosing spondylitis	0.0021	0.00244	CcSEcCtD
Disopyramide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.0021	0.00243	CcSEcCtD
Disopyramide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00209	0.00242	CcSEcCtD
Disopyramide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00209	0.00242	CcSEcCtD
Disopyramide—Malaise—Methotrexate—ankylosing spondylitis	0.00204	0.00236	CcSEcCtD
Disopyramide—Vertigo—Methotrexate—ankylosing spondylitis	0.00203	0.00235	CcSEcCtD
Disopyramide—Urticaria—Dexamethasone—ankylosing spondylitis	0.00201	0.00233	CcSEcCtD
Disopyramide—Urticaria—Betamethasone—ankylosing spondylitis	0.00201	0.00233	CcSEcCtD
Disopyramide—Dizziness—Prednisolone—ankylosing spondylitis	0.00201	0.00233	CcSEcCtD
Disopyramide—Asthenia—Triamcinolone—ankylosing spondylitis	0.002	0.00232	CcSEcCtD
Disopyramide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.002	0.00232	CcSEcCtD
Disopyramide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.002	0.00232	CcSEcCtD
Disopyramide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.002	0.00232	CcSEcCtD
Disopyramide—Insomnia—Prednisone—ankylosing spondylitis	0.002	0.00231	CcSEcCtD
Disopyramide—Paraesthesia—Prednisone—ankylosing spondylitis	0.00198	0.0023	CcSEcCtD
Disopyramide—Pruritus—Triamcinolone—ankylosing spondylitis	0.00198	0.00229	CcSEcCtD
Disopyramide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00197	0.00229	CcSEcCtD
Disopyramide—Dyspepsia—Prednisone—ankylosing spondylitis	0.00194	0.00225	CcSEcCtD
Disopyramide—Chest pain—Methotrexate—ankylosing spondylitis	0.00192	0.00223	CcSEcCtD
Disopyramide—Decreased appetite—Prednisone—ankylosing spondylitis	0.00192	0.00222	CcSEcCtD
Disopyramide—Rash—Prednisolone—ankylosing spondylitis	0.00192	0.00222	CcSEcCtD
Disopyramide—Dermatitis—Prednisolone—ankylosing spondylitis	0.00191	0.00222	CcSEcCtD
Disopyramide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00191	0.00221	CcSEcCtD
Disopyramide—Fatigue—Prednisone—ankylosing spondylitis	0.0019	0.00221	CcSEcCtD
Disopyramide—Headache—Prednisolone—ankylosing spondylitis	0.0019	0.00221	CcSEcCtD
Disopyramide—Discomfort—Methotrexate—ankylosing spondylitis	0.0019	0.0022	CcSEcCtD
Disopyramide—Constipation—Prednisone—ankylosing spondylitis	0.00189	0.00219	CcSEcCtD
Disopyramide—Confusional state—Methotrexate—ankylosing spondylitis	0.00186	0.00216	CcSEcCtD
Disopyramide—Dizziness—Triamcinolone—ankylosing spondylitis	0.00185	0.00214	CcSEcCtD
Disopyramide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00184	0.00214	CcSEcCtD
Disopyramide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00182	0.00211	CcSEcCtD
Disopyramide—Asthenia—Betamethasone—ankylosing spondylitis	0.00182	0.00211	CcSEcCtD
Disopyramide—Asthenia—Dexamethasone—ankylosing spondylitis	0.00182	0.00211	CcSEcCtD
Disopyramide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00181	0.00209	CcSEcCtD
Disopyramide—Nausea—Prednisolone—ankylosing spondylitis	0.0018	0.00209	CcSEcCtD
Disopyramide—Pruritus—Betamethasone—ankylosing spondylitis	0.00179	0.00208	CcSEcCtD
Disopyramide—Pruritus—Dexamethasone—ankylosing spondylitis	0.00179	0.00208	CcSEcCtD
Disopyramide—Skin disorder—Methotrexate—ankylosing spondylitis	0.00179	0.00208	CcSEcCtD
Disopyramide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00178	0.00207	CcSEcCtD
Disopyramide—Vomiting—Triamcinolone—ankylosing spondylitis	0.00178	0.00206	CcSEcCtD
Disopyramide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00177	0.00205	CcSEcCtD
Disopyramide—Rash—Triamcinolone—ankylosing spondylitis	0.00176	0.00204	CcSEcCtD
Disopyramide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00176	0.00204	CcSEcCtD
Disopyramide—Anorexia—Methotrexate—ankylosing spondylitis	0.00176	0.00204	CcSEcCtD
Disopyramide—Rash—Methylprednisolone—ankylosing spondylitis	0.00176	0.00204	CcSEcCtD
Disopyramide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00176	0.00204	CcSEcCtD
Disopyramide—Urticaria—Prednisone—ankylosing spondylitis	0.00175	0.00203	CcSEcCtD
Disopyramide—Headache—Triamcinolone—ankylosing spondylitis	0.00175	0.00203	CcSEcCtD
Disopyramide—Headache—Methylprednisolone—ankylosing spondylitis	0.00175	0.00202	CcSEcCtD
Disopyramide—Body temperature increased—Prednisone—ankylosing spondylitis	0.00175	0.00202	CcSEcCtD
Disopyramide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00173	0.00201	CcSEcCtD
Disopyramide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00173	0.00201	CcSEcCtD
Disopyramide—Hypotension—Methotrexate—ankylosing spondylitis	0.00172	0.002	CcSEcCtD
Disopyramide—Dizziness—Dexamethasone—ankylosing spondylitis	0.00168	0.00194	CcSEcCtD
Disopyramide—Dizziness—Betamethasone—ankylosing spondylitis	0.00168	0.00194	CcSEcCtD
Disopyramide—Insomnia—Methotrexate—ankylosing spondylitis	0.00167	0.00193	CcSEcCtD
Disopyramide—Nausea—Triamcinolone—ankylosing spondylitis	0.00166	0.00192	CcSEcCtD
Disopyramide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00166	0.00192	CcSEcCtD
Disopyramide—Nausea—Methylprednisolone—ankylosing spondylitis	0.00166	0.00192	CcSEcCtD
Disopyramide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00165	0.00191	CcSEcCtD
Disopyramide—Somnolence—Methotrexate—ankylosing spondylitis	0.00164	0.0019	CcSEcCtD
Disopyramide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00162	0.00188	CcSEcCtD
Disopyramide—Vomiting—Betamethasone—ankylosing spondylitis	0.00161	0.00187	CcSEcCtD
Disopyramide—Vomiting—Dexamethasone—ankylosing spondylitis	0.00161	0.00187	CcSEcCtD
Disopyramide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.0016	0.00186	CcSEcCtD
Disopyramide—Rash—Dexamethasone—ankylosing spondylitis	0.0016	0.00185	CcSEcCtD
Disopyramide—Rash—Betamethasone—ankylosing spondylitis	0.0016	0.00185	CcSEcCtD
Disopyramide—Dermatitis—Betamethasone—ankylosing spondylitis	0.0016	0.00185	CcSEcCtD
Disopyramide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.0016	0.00185	CcSEcCtD
Disopyramide—Fatigue—Methotrexate—ankylosing spondylitis	0.00159	0.00184	CcSEcCtD
Disopyramide—Headache—Dexamethasone—ankylosing spondylitis	0.00159	0.00184	CcSEcCtD
Disopyramide—Headache—Betamethasone—ankylosing spondylitis	0.00159	0.00184	CcSEcCtD
Disopyramide—Asthenia—Prednisone—ankylosing spondylitis	0.00158	0.00184	CcSEcCtD
Disopyramide—Pain—Methotrexate—ankylosing spondylitis	0.00158	0.00183	CcSEcCtD
Disopyramide—Pruritus—Prednisone—ankylosing spondylitis	0.00156	0.00181	CcSEcCtD
Disopyramide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00152	0.00176	CcSEcCtD
Disopyramide—Diarrhoea—Prednisone—ankylosing spondylitis	0.00151	0.00175	CcSEcCtD
Disopyramide—Nausea—Betamethasone—ankylosing spondylitis	0.00151	0.00175	CcSEcCtD
Disopyramide—Nausea—Dexamethasone—ankylosing spondylitis	0.00151	0.00175	CcSEcCtD
Disopyramide—Urticaria—Methotrexate—ankylosing spondylitis	0.00147	0.0017	CcSEcCtD
Disopyramide—Dizziness—Prednisone—ankylosing spondylitis	0.00146	0.00169	CcSEcCtD
Disopyramide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00146	0.00169	CcSEcCtD
Disopyramide—Vomiting—Prednisone—ankylosing spondylitis	0.0014	0.00163	CcSEcCtD
Disopyramide—Rash—Prednisone—ankylosing spondylitis	0.00139	0.00161	CcSEcCtD
Disopyramide—Dermatitis—Prednisone—ankylosing spondylitis	0.00139	0.00161	CcSEcCtD
Disopyramide—Headache—Prednisone—ankylosing spondylitis	0.00138	0.0016	CcSEcCtD
Disopyramide—Asthenia—Methotrexate—ankylosing spondylitis	0.00132	0.00153	CcSEcCtD
Disopyramide—Nausea—Prednisone—ankylosing spondylitis	0.00131	0.00152	CcSEcCtD
Disopyramide—Pruritus—Methotrexate—ankylosing spondylitis	0.00131	0.00151	CcSEcCtD
Disopyramide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00126	0.00146	CcSEcCtD
Disopyramide—Dizziness—Methotrexate—ankylosing spondylitis	0.00122	0.00141	CcSEcCtD
Disopyramide—Vomiting—Methotrexate—ankylosing spondylitis	0.00117	0.00136	CcSEcCtD
Disopyramide—Rash—Methotrexate—ankylosing spondylitis	0.00116	0.00135	CcSEcCtD
Disopyramide—Dermatitis—Methotrexate—ankylosing spondylitis	0.00116	0.00135	CcSEcCtD
Disopyramide—Headache—Methotrexate—ankylosing spondylitis	0.00116	0.00134	CcSEcCtD
Disopyramide—Nausea—Methotrexate—ankylosing spondylitis	0.0011	0.00127	CcSEcCtD
